Article
Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.
British journal of clinical pharmacology - 1 Aug 2014
Benz-de Bretagne Isabelle, Zahr Noël, Le Gouge Amélie, Hulot Jean-Sébastien, Houillier Caroline, Hoang-Xuan Khe, Gyan Emmanuel, Lissandre Séverine, Choquet Sylvain, Le Guellec Chantal
Abstract excerpt
AIMS: The urinary coproporphyrin I/(I + III) ratio may be a surrogate for MRP2 activity. We conducted a prospective study in patients receiving methotrexate (MTX) to examine the relationship between this ratio and the pharmacokinetics of a MRP2 substrate. METHODS: Three urine samples were collect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
